The Journal of Clinical Psychiatry presents highlights of the teleconference series "Revisiting the Relapse and Remission Roller Coaster: Safety and Efficacy of Novel Schizophrenia Treatments," which was held on September 13, 2022.This report was prepared and independently developed by the CME
No takes yet. Share an insight, caveat, or question.
Velligan et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: